Código QR (código de barras bidimensional)

Amivantamab: A narrative drug review

Epidermal growth factor receptor (EGFR) activating mutations are known oncogenic drivers in non-small-cell lung cancer (NSCLC), with 85% attributable to an exon 19 deletion or exon 21 L858R point substitution. The next most common is an exon 20 insertion mutation (Ex20Ins), which results in an alter...

ver descrição completa

Na minha lista:
Principais autores: Anupa John, Vanita Noronha, Ajaykumar Singh, Nandini Menon, Kumar Prabhash
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Medknow Publications 2023-01-01
coleção:Cancer Research, Statistics, and Treatment
Assuntos:
exon 20ins
exon 20
nsclc
met
bispecific antibody
humanized
jnj-61186372
Acesso em linha:http://www.crstonline.com/article.asp?issn=2590-3233;year=2023;volume=6;issue=2;spage=261;epage=271;aulast=John
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados